Compounds > deferoxamine

deferoxamine and mitomycin

deferoxamine has been researched along with mitomycin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Golub, SH; Ramsdell, FJ; Shau, H1
Gutteridge, JM; Quinlan, GJ; Wilkins, S1
Anderson, D; Brinkworth, MH; Hughes, JA; Yardley-Jones, A; Yu, TW1

Reviews

1 review(s) available for deferoxamine and mitomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for deferoxamine and mitomycin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Role of proliferation in LAK cell development.
    Cancer immunology, immunotherapy : CII, 1988, Volume: 26, Issue:2

    Topics: Cell Separation; Concanavalin A; Cytotoxicity, Immunologic; Deferoxamine; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Mitomycin; Mitomycins; Phytohemagglutinins; Recombinant Proteins

1988
Mitomycin C-induced deoxyribose degradation inhibited by superoxide dismutase. A reaction involving iron, hydroxyl and semiquinone radicals.
    FEBS letters, 1984, Feb-13, Volume: 167, Issue:1

    Topics: Animals; Benzoquinones; Cattle; Deferoxamine; Deoxyribose; Edetic Acid; Humans; Hydroxides; Hydroxyl Radical; Iron; Mitomycin; Mitomycins; Pentetic Acid; Quinones; Superoxide Dismutase; Xanthine Oxidase

1984
Modulation of ras p21 oncoprotein levels and DNA strand breakage in human cells with chemotherapeutic agents and/or deferoxamine.
    Teratogenesis, carcinogenesis, and mutagenesis, 1998, Volume: 18, Issue:5

    Topics: Antineoplastic Agents; Caco-2 Cells; Deferoxamine; DNA; DNA Damage; Doxorubicin; Free Radicals; Humans; Mitomycin; Proto-Oncogene Proteins p21(ras)

1998